(Q39137771)

9 September 2017

MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). (English)

1 reference

9 September 2017

1 reference

Xuyang Jiao

1

1 reference

9 September 2017

Lin Zhao

2

1 reference

9 September 2017

Mengtao Ma

3

1 reference

9 September 2017

Xuefeng Bai

4

1 reference

9 September 2017

Miao He

5

1 reference

9 September 2017

Yuanyuan Yan

6

1 reference

9 September 2017

Yan Wang

7

1 reference

9 September 2017

Qiuchen Chen

8

1 reference

9 September 2017

Xinnan Zhao

9

1 reference

9 September 2017

Mingyi Zhou

10

1 reference

9 September 2017

Zeshi Cui

11

1 reference

9 September 2017

Zhihong Zheng

12

1 reference

9 September 2017

Enhua Wang

13

1 reference

9 September 2017

Minjie Wei

14

1 reference

9 September 2017

language of work or name

English

0 references

publication date

19 June 2013

1 reference

Breast Cancer Research and Treatment

9 September 2017

1 reference

9 September 2017

139

1 reference

9 September 2017

3

1 reference

9 September 2017

717-730

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-013-2607-x

9 September 2017

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Reversal of breast cancer resistance protein (BCRP/ABCG2)‐mediated drug resistance by novobiocin, a coumermycin antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Molecular biology of breast cancer stem cells: potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Cancer regulator microRNA: potential relevance in diagnosis, prognosis and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

The 3' untranslated region of the membrane-bound IL-1R accessory protein mRNA confers tissue-specific destabilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Extensive modulation of a set of microRNAs in primary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Dynamic regulation of miRNA expression in ordered stages of cellular development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

miR-181a and miR-630 regulate cisplatin-induced cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

TGF-β upregulates miR-181a expression to promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

MIR181A regulates starvation- and rapamycin-induced autophagy through targeting of ATG5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Open source clustering software

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Java Treeview--extensible visualization of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

A novel two mode-acting inhibitor of ABCG2-mediated multidrug transport and resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

miR-181a regulates cap-dependent translation of p27(kip1) mRNA in myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

PI3K/mTOR inhibition can impair tumor invasion and metastasis in vivo despite a lack of antiproliferative action in vitro: implications for targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Resistance to topoisomerase poisons due to loss of DNA mismatch repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Sensitivity to TOP2 targeting chemotherapeutics is regulated by Oct1 and FILIP1L

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2607-X

10.1007/S10549-013-2607-X

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference